- Home
- PHIO vs HIND Comparison
PHIO vs HIND Comparison
Compare PHIO & HIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHIO
- HIND
- Stock Information
- Founded
- PHIO 2011
- HIND N/A
- Country
- PHIO United States
- HIND United States
- Employees
- PHIO N/A
- HIND N/A
- Industry
- PHIO Biotechnology: Pharmaceutical Preparations
- HIND
- Sector
- PHIO Health Care
- HIND
- Exchange
- PHIO Nasdaq
- HIND Nasdaq
- Market Cap
- PHIO 12.1M
- HIND 10.3M
- IPO Year
- PHIO N/A
- HIND 2016
- Fundamental
- Price
- PHIO $2.04
- HIND $7.95
- Analyst Decision
- PHIO Strong Buy
- HIND
- Analyst Count
- PHIO 3
- HIND 0
- Target Price
- PHIO $10.67
- HIND N/A
- AVG Volume (30 Days)
- PHIO 139.7K
- HIND N/A
- Earning Date
- PHIO 08-14-2025
- HIND N/A
- Dividend Yield
- PHIO N/A
- HIND N/A
- EPS Growth
- PHIO N/A
- HIND N/A
- EPS
- PHIO N/A
- HIND N/A
- Revenue
- PHIO N/A
- HIND N/A
- Revenue This Year
- PHIO N/A
- HIND N/A
- Revenue Next Year
- PHIO N/A
- HIND N/A
- P/E Ratio
- PHIO N/A
- HIND N/A
- Revenue Growth
- PHIO N/A
- HIND N/A
- 52 Week Low
- PHIO $0.97
- HIND N/A
- 52 Week High
- PHIO $9.79
- HIND N/A
- Technical
- Relative Strength Index (RSI)
- PHIO 42.33
- HIND N/A
- Support Level
- PHIO $1.96
- HIND N/A
- Resistance Level
- PHIO $2.13
- HIND N/A
- Average True Range (ATR)
- PHIO 0.10
- HIND 0.00
- MACD
- PHIO 0.01
- HIND 0.00
- Stochastic Oscillator
- PHIO 44.83
- HIND 0.00
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.